We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $8.34B
1-Year Est. Return 165.53%
This Fund
S&P 500
This Quarter Est. Return
+77.9%
1 Year Est. Return
+165.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.34B
AUM Growth
+$2.35B
Cap. Flow
-$42M
Cap. Flow %
-0.5%
Top 10 Hldgs %
46.57%
Holding
644
New
20
Increased
132
Reduced
424
Closed
57

Top Buys

Rank Stock Value
1
INIO
INNIO N.V.
INIO
+$177M
2
AMD icon
Advanced Micro Devices
AMD
+$119M
3
FORM icon
FormFactor
FORM
+$101M
4
CBRS
Cerebras Systems
CBRS
+$70.1M
5
ONTO icon
Onto Innovation
ONTO
+$64.5M

Top Sells

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$220M
2
LITE icon
Lumentum
LITE
+$219M
3
TSLA icon
Tesla
TSLA
+$50.1M
4
CIEN icon
Ciena
CIEN
+$43.3M
5
MSFT icon
Microsoft
MSFT
+$42.6M

Sector Composition

Rank Sector Weight
1 Technology 66.11%
2 Communication Services 9.64%
3 Consumer Discretionary 8.42%
4 Industrials 4.35%
5 Healthcare 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDXS icon
576
Codexis
CDXS
$160M
$4.32K ﹤0.01%
1,913
+105
+6% +$261
ARCT icon
577
Arcturus Therapeutics
ARCT
$450M
$4.11K ﹤0.01%
611
-42
-6% -$331
LFCR icon
578
Lifecore Biomedical
LFCR
$167M
$4.09K ﹤0.01%
779
-57
-7% -$287
BCYC
579
Bicycle Therapeutics
BCYC
$301M
$4.08K ﹤0.01%
962
-70
-7% -$321
LENZ
580
LENZ Therapeutics
LENZ
$187M
$3.78K ﹤0.01%
665
-23
-3% -$185
QSI icon
581
Quantum-Si Incorporated
QSI
$168M
$3.7K ﹤0.01%
4,185
+462
+12% +$440
PYXS icon
582
Pyxis Oncology
PYXS
$324M
$3.69K ﹤0.01%
1,226
-90
-7% -$172
CRBU icon
583
Caribou Biosciences
CRBU
$168M
$3.43K ﹤0.01%
1,951
-148
-7% -$293
MENS
584
Jyong Biotech
MENS
$177M
$3.23K ﹤0.01%
1,559
-118
-7% -$250
AARD
585
Aardvark Therapeutics
AARD
$118M
$2.6K ﹤0.01%
452
-31
-6% -$145
PEPG icon
586
PepGen
PEPG
$215M
$2.57K ﹤0.01%
1,427
-106
-7% -$172
BDTX icon
587
Black Diamond Therapeutics
BDTX
$122M
$2.19K ﹤0.01%
1,185
-87
-7% -$213
ACLX
588
DELISTED
Arcellx
ACLX
– –
-1,299
Closed -$149K
AHRT
589
AH Realty Trust
AHRT
$493M
– –
-1,227
Closed -$6.75K
AMKR icon
590
Amkor Technology
AMKR
$11.9B
– –
-43,738
Closed -$1.97M
APLS
591
DELISTED
Apellis Pharmaceuticals
APLS
– –
-2,841
Closed -$114K
ASTS icon
592
AST SpaceMobile
ASTS
$18.7B
– –
-144
Closed -$11.9K
CELH icon
593
Celsius Holdings
CELH
$7.76B
– –
-54,395
Closed -$1.93M
CF icon
594
CF Industries
CF
$20.2B
– –
-3,547
Closed -$461K
CHTR icon
595
Charter Communications
CHTR
$18.1B
– –
-26,520
Closed -$5.73M
CMI icon
596
Cummins
CMI
$77.2B
– –
-72
Closed -$38.7K
CNTA
597
DELISTED
Centessa Pharmaceuticals
CNTA
– –
-2,166
Closed -$86K
COHR icon
598
Coherent
COHR
$55.2B
– –
-98,000
Closed -$23.3M
COIN icon
599
Coinbase
COIN
$48.7B
– –
-118
Closed -$20.6K
CSGP icon
600
CoStar Group
CSGP
$12.5B
– –
-86,853
Closed -$3.5M
22 23
24
25 26

Similar funds

GLF
Groupe la Francaise Paris, France $8.31B AUM 37.53% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
MWM
Modern Wealth Management Lenexa, Kansas $8.4B AUM 21.02% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $8.41B AUM

GF Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, GF Fund Management held 644 positions worth $8.34B, up 39% from $5.98B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

GF Fund Management's Q2 2026 filing shows 20 new, 132 increased, 424 reduced and 57 closed positions. Its largest new stake was INNIO N.V.: 4,970,000 shares worth $197M. The largest sale was Tower Semiconductor, an estimated $220M.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 54% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q2 2026 buy was INNIO N.V.: 4,970,000 shares worth $197M.
  • GF Fund Management added most to Advanced Micro Devices in Q2 2026, an estimated $119M increase.
  • GF Fund Management's biggest Q2 2026 reduction was Tower Semiconductor, cutting an estimated $220M.
  • GF Fund Management fully exited Coherent in Q2 2026, selling an estimated $23.3M.
  • GF Fund Management's ten largest holdings make up 47% of its $8.34B portfolio in Q2 2026.
  • GF Fund Management opened 20 new positions and closed 57 in Q2 2026.
  • GF Fund Management's portfolio value rose 39% quarter-over-quarter to $8.34B.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.